Atea Pharmaceuticals Inc (NQ: AVIR )
3.900
+0.120
(+3.17%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Atea Pharmaceuticals Inc
![](https://ml.globenewswire.com/media/1506ab30-7618-4ed0-98de-e3815adb3aa6/small/avir-png.png)
![](https://ml.globenewswire.com/media/1506ab30-7618-4ed0-98de-e3815adb3aa6/small/avir-png.png)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/1506ab30-7618-4ed0-98de-e3815adb3aa6/small/avir-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/09/26/aapharma_7.png?width=1200&height=800&fit=crop)
Atea Pharma's Investigational Dengue Treatment Fast Tracked In US
September 26, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/13/aapharma_8.png?width=1200&height=800&fit=crop)
Atea Pharmaceuticals To Advance Global Late-Stage COVID-19 Study of Bemnifosbuvir
September 13, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_482.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/short_image_19.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_5970.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/1506ab30-7618-4ed0-98de-e3815adb3aa6/small/avir-png.png)
![](https://ml.globenewswire.com/media/1506ab30-7618-4ed0-98de-e3815adb3aa6/small/avir-png.png)
![](https://www.investors.com/wp-content/uploads/2017/10/stock-merck-01-company.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_6053.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2119.jpeg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/analyst_ratings_image_502.jpeg?width=720)
![](https://www.wstnn.com/wp-content/uploads/2018/08/Screen-Shot-2018-08-12-at-12.49.24-PM.png)
![](https://cdn.benzinga.com/files/images/story/2022/05/10/analysis-gea8109339_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_2930.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_5544.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/valuestock_image_986.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_573.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_130.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_3421.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_563.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2185.jpeg)
![](https://www.investors.com/wp-content/uploads/2022/02/TECH1-paxlovid-021122-AP.jpg)
![](https://cdn.benzinga.com/files/images/story/2012/medicine-1309148_1920_405.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220112005969/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.